Skip to main content
logo
Iovance Biotherapeutics, Inc. (FRA:2LB)
Germany flag Germany · Delayed Price · Currency is EUR
2.231
-0.094 (-4.04%)
Last updated: Jan 9, 2026, 2:33 PM CET

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Autologous Tumor Infiltrating Lymphocyte Cell Therapies
164.07M
Log In
Autologous Tumor Infiltrating Lymphocyte Cell Therapies Growth
13698.99%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
161.04M
Log In
United States Growth
13444.41%
Log In
Rest of World
3.03M
Log In